Revvity Pre-Tax Profit Margin 2010-2025 | RVTY

Current and historical pre-tax profit margin for Revvity (RVTY) from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Revvity pre-tax profit margin for the three months ending March 31, 2025 was .
Revvity Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2025-03-31 $2.77B $0.33B 12.06%
2024-12-31 $2.76B $0.32B 11.51%
2024-09-30 $2.72B $0.25B 9.29%
2024-06-30 $2.71B $0.20B 7.53%
2024-03-31 $2.73B $0.19B 6.93%
2023-12-31 $2.75B $0.18B 6.65%
2023-09-30 $2.80B $0.29B 10.37%
2023-06-30 $2.84B $0.32B 11.31%
2023-03-31 $3.02B $0.46B 15.05%
2022-12-31 $3.31B $0.65B 19.66%
2022-09-30 $3.00B $0.78B 25.82%
2022-06-30 $3.15B $0.83B 26.29%
2022-03-31 $3.48B $0.95B 27.23%
2021-12-31 $3.83B $1.20B 31.43%
2021-09-30 $3.63B $1.31B 36.01%
2021-06-30 $3.74B $1.41B 37.67%
2021-03-31 $3.32B $1.25B 37.54%
2020-12-31 $2.66B $0.80B 30.08%
2020-09-30 $3.23B $0.50B 15.43%
2020-06-30 $2.98B $0.33B 11.02%
2020-03-31 $2.89B $0.24B 8.14%
2019-12-31 $2.88B $0.24B 8.22%
2019-09-30 $2.84B $0.25B 8.85%
2019-06-30 $2.80B $0.27B 9.49%
2019-03-31 $2.78B $0.27B 9.56%
2018-12-31 $2.78B $0.26B 9.29%
2018-09-30 $2.66B $0.26B 9.76%
2018-06-30 $2.54B $0.29B 11.29%
2018-03-31 $2.39B $0.29B 11.98%
2017-12-31 $2.26B $0.30B 13.16%
2017-09-30 $2.18B $0.29B 13.06%
2017-06-30 $2.14B $0.25B 11.44%
2017-03-31 $2.13B $0.24B 11.03%
2016-12-31 $2.12B $0.24B 11.54%
2016-09-30 $2.00B $0.22B 10.76%
2016-06-30 $2.05B $0.21B 10.45%
2016-03-31 $2.08B $0.21B 10.12%
2015-12-31 $2.11B $0.21B 9.93%
2015-09-30 $2.10B $0.14B 6.87%
2015-06-30 $2.07B $0.13B 6.17%
2015-03-31 $2.07B $0.13B 6.39%
2014-12-31 $2.07B $0.12B 5.99%
2014-09-30 $2.22B $0.22B 9.74%
2014-06-30 $2.20B $0.21B 9.74%
2014-03-31 $2.18B $0.18B 8.25%
2013-12-31 $2.16B $0.16B 7.60%
2013-09-30 $2.13B $0.06B 2.77%
2013-06-30 $2.12B $0.04B 2.08%
2013-03-31 $2.10B $0.06B 2.62%
2012-12-31 $2.11B $0.06B 2.61%
2012-09-30 $2.08B $0.05B 2.59%
2012-06-30 $2.03B $0.06B 2.72%
2012-03-31 $1.98B $0.05B 2.62%
2011-12-31 $1.92B $0.06B 3.34%
2011-09-30 $1.85B $0.15B 8.23%
2011-06-30 $1.81B $0.16B 8.55%
2011-03-31 $1.76B $0.18B 9.97%
2010-12-31 $1.70B $0.17B 9.75%
2010-09-30 $1.54B $0.15B 9.45%
2010-06-30 $1.49B $0.13B 8.51%
2010-03-31 $1.51B $0.11B 7.02%
2009-12-31 $1.55B $0.10B 6.39%
Sector Industry Market Cap Revenue
Medical Medical Services $10.588B $2.755B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $133.694B 25.08
Elevance Health (ELV) United States $90.401B 11.66
CVS Health (CVS) United States $78.570B 9.77
Cencora (COR) United States $56.472B 19.65
DiDi Global (DIDIY) China $22.450B 34.07
Natera (NTRA) United States $20.631B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.588B 13.33
EUROFINS SCIENT (ERFSF) Luxembourg $12.514B 0.00
CochLear (CHEOY) Australia $11.382B 0.00
ICON (ICLR) Ireland $10.225B 9.51
Viatris (VTRS) United States $9.953B 3.42
Doximity (DOCS) United States $9.475B 44.13
Avantor (AVTR) United States $8.552B 12.43
HealthEquity (HQY) United States $8.545B 42.04
Medpace Holdings (MEDP) United States $8.501B 22.58
Sonic Healthcare (SKHHY) Australia $8.263B 0.00
Charles River Laboratories (CRL) United States $6.630B 12.99
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.137B 38.29
Bausch + Lomb (BLCO) Canada $3.955B 23.31
Sotera Health (SHC) United States $3.503B 19.90
Alignment Healthcare (ALHC) United States $3.033B 0.00
Surgery Partners (SGRY) United States $2.905B 37.78
Concentras Parent (CON) United States $2.803B 16.20
Organon (OGN) United States $2.191B 2.33
Ardent Health Partners (ARDT) United States $2.137B 9.11
GeneDx Holdings (WGS) United States $1.934B 74.48
Premier (PINC) United States $1.899B 14.41
Progyny (PGNY) United States $1.816B 39.98
PACS (PACS) United States $1.506B 0.00
GoodRx Holdings (GDRX) United States $1.354B 27.07
Pediatrix Medical (MD) United States $1.303B 9.91
Teladoc Health (TDOC) United States $1.223B 0.00
Establishment Labs Holdings (ESTA) $1.037B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
Agilon Health (AGL) United States $0.973B 0.00
CareDx (CDNA) United States $0.949B 14.83
Nutex Health (NUTX) United States $0.941B 14.21
AMN Healthcare Services Inc (AMN) United States $0.846B 7.92
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.722B 4.86
InnovAge Holding (INNV) United States $0.554B 0.00
Enhabit (EHAB) United States $0.528B 43.46
Auna S.A (AUNA) Luxembourg $0.506B 11.40
LifeMD (LFMD) United States $0.489B 0.00
Sonida Senior Living (SNDA) United States $0.467B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.403B 0.00
SBC Medicals (SBC) United States $0.360B 0.00
Performant Healthcare (PHLT) United States $0.204B 0.00
Oncology Institute (TOI) United States $0.202B 0.00
Beauty Health (SKIN) United States $0.195B 0.00
KindlyMD (KDLY) United States $0.137B 0.00
DocGo (DCGO) United States $0.131B 21.33
So-Young (SY) China $0.089B 0.00
OncoCyte (OCX) United States $0.088B 0.00
Sera Prognostics (SERA) United States $0.072B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
Biodesix (BDSX) United States $0.058B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Pheton Holdings (PTHL) China $0.036B 0.00
Basel Medical Group (BMGL) Singapore $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00